Efficiency of Antagonist Drugs of the Cellular Transcriptomic Signature of Influenza A Virus Infection.

NCT03212716 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

85

Enrollment

OTHER

Sponsor class

Stopped rate of inclusion and study affected by covid-19 epidemic

Conditions

Flu

Interventions

DRUG: Oseltamivir
DRUG: Diltiazem
DRUG: Placebos

Sponsor

University Hospital, Lille

Collaborators

[object Object]